# Study of HBV-001 D1 in Healthy Adults

> **NCT00936429** · PHASE1 · COMPLETED · sponsor: **Hawaii Biotech, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Dengue Fever

## Interventions

- **BIOLOGICAL:** DEN1-80E (HBV-001 D1 + 3.5 mg Alhydrogel)
- **BIOLOGICAL:** Placebo for DEN1-80E

## Key facts

- **NCT ID:** NCT00936429
- **Lead sponsor:** Hawaii Biotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-07
- **Final completion:** 2011-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2011-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00936429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00936429, "Study of HBV-001 D1 in Healthy Adults". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00936429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*